Howard began his career in life sciences in 1969 with Pfizer. He continued his marketing, sales and product development work with Baxter and Bayer until 1979. Late in 1979 he founded Advanced Bioresearch Associates (ABA) which grew to be the premier Life Sciences—FDA Regulatory Affairs consulting firm for Life Science company clients, worldwide. ABA strategically focused to make business sense of developing medical products in a heavily regulated environment. Howard served as President, CEO and Chairman of ABA for 20 years, securing regulatory approval for hundreds of medical products, including drugs, biotherapeutics, medical devices and in-vitro diagnostics.
In 1999, with a vision of alleviating some of the life science industry's pain through IT innovation, Howard founded BioQ Inc. to address the time and cost of managing information associated with medical products within life science industry. Howard served as President, CEO of BioQ where he was dedicated to creating a significantly innovative, smart automated system to expedite the medical product information process. Under Howard's leadership, BioQ developed groundbreaking IT intellectual property specific to managing unstructured data in any language.
Howard in 2001 joined Sun Microsystems, Inc, as its Group Director of Global Life and Health Sciences. At Sun, Howard led the worldwide sales and marketing teams active within 140 nations. While at Sun, Howard founded the LSIT Global Institute. A non-profit organization, the Life Sciences Information Technology (LSIT) Global Institute is chartered with one purpose: To develop an independent source of trusted IT guidance referred to as Good Informatics Practices (GIP) guidelines for the global life and health sciences community.
Howard firmly believes that if we, the public and governments, can completely trust Information Technology utilized within the life and health sciences community, it will enable rapid improvement of global public health. At GLS, Howard leverages his regulatory affairs, IT and business management knowledge to assist GLS client's success.
Howard has utilized his 27 years as successful CEO by participating on many Boards over the years, including; BIOCOM, Quorex Pharmaceuticals, Stryker Corp. (Howmedica, Osteonics), the Sidney Kimmel Cancer Center, PharmaPrint, Biomatters, Inc. and many others. Howard also teaches at the UCSD School of Pharmacy and Pharmaceutical Sciences and Rady School of Management at U.C. San Diego. Howard remains active in the industry as a keynote speaker and panel moderator, often with a focus on the IT convergence into the regulated Life Sciences Industry, Computational Predictive Modeling and Personalized Medicine. In 1996 he led the formation of, and played a significant role in designing, the worlds first Master in Regulatory Affairs (MRA) degree program with the US–FDA and California State University. The program was the first to offer an accredited distant learning curriculum on this very complicated subject.
